10-month-old girl swallows LED bulb when were busy in celebrating Diwali

Mangaluru, Mar 29: Infosys Foundation Chairperson Sudha Murty has sent the second consignment of N95 Masks, Personal Protection Equipment (PPE) and Sanitisers worth about Rs 73 lakhs, City police Commissioner Dr P S Harsha said on Sunday.

"These will be primarily used by Doctors, Nurses and Paramedics of Wenlock Hospital here and masks by the frontline staff of ASHA and police at risk of exposure to the virus,” Dr Harsha tweeted on Sunday.

The district has received the first consignment with critical medical equipment worth Rs 28 lakh from the Infosys foundation on Saturday, March 28.

Bengaluru, Jan 24: After the visit of fact finding committee members to the spot, the Christian community here decided to submit a report to the state government urging to install a 114-ft. statue of Jesus Christ at Kapala Betta in Kanakapura taluk of Ramanagaram district, Congress MLC Ivan D’souza said here on Thursday.

While talking to media, Mr D’souza said the committee would submit the report to Chief Minister B.S. Yediyurappa and Revenue Minster R. Ashok and urge the government to construct the statue at the earliest.

The RSS and other BJP outfits have strongly opposed the installation, following which the government ordered suspension of the work. A few days ago, Kalladka Prabhakar, RSS ideologue, took out a rally in Kanakapura opposing the installation.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.